Skip to main content
Clinical Trials/JPRN-jRCTs062180027
JPRN-jRCTs062180027
Recruiting
Phase 1

The development of treatment using neurofeedback for patients with mood disorder: an exploratory study through neuroimaging approaches - The development of treatment for mood disorder by NFB

Okada Go0 sites130 target enrollmentFebruary 26, 2019

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Mood disorders (major depressive disorder and bipolar disorder) and healthy volunteers
Sponsor
Okada Go
Enrollment
130
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 26, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Okada Go

Eligibility Criteria

Inclusion Criteria

  • \[For patients/clients ]
  • 1\) Aged 20\-80 years old
  • 2\) Being diagnosed as major depressive disorder or bipolar disorder (Type I, Type II) according to DSM\-IV\-TR or DSM\-V criteria
  • 3\) Present ongoing episode of major depressive symptoms
  • 4\) Present treatment\-resistance (scores 14 points or above out of 17 items on the Hamilton Rating Scale for Depression even after \>\=4 weeks of treatment with sufficient amount of more than 1 kinds of anti\-depressants) or low treatment\-tolerance (insufficient administration due to side\-effects while taking more than 1 kinds of anti\-depressants)
  • 5\) Satisfactory informed consent obtained from the participant him/herself
  • \[For healthy control]
  • 1\) Aged 20\-80 years old
  • 2\) Not history of psychiatric disorders
  • 3\) Not having current serious medical illness

Exclusion Criteria

  • 1\) Decisionally impaired individuals who has diminished capacity to understand the aim of the research
  • 2\) Physically impaired individuals who are not able to complete the experiment
  • 3\) Subjects who are contraindicated for the use of MRI
  • Having an implanted heart pace\-maker
  • Having implanted cerebral (arteries) clips
  • Having implanted neural/nerve stimulators
  • Having implanted pumps
  • Having work experience in a metal industry or possibility of metal residues remaining in the body
  • Having metal\-tattoos (including tattooed eye\-lining)
  • Being pregnant, or having possibility of being pregnant

Outcomes

Primary Outcomes

Not specified

Similar Trials